EU Says Nitrosamine Risk Info Also Needed For New Drug Filings

Incomplete Info May Impact Granting Of Marketing Authorization

 
• By Vibha Sharma
  
Research analyst adding reagent to drug to keep tracking chemical reaction - Image
EU Has Updated Guidance On Nitrosamine Risk Evaluations • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance